financetom
Business
financetom
/
Business
/
Unity Software Insider Sold Shares Worth $300,525, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Unity Software Insider Sold Shares Worth $300,525, According to a Recent SEC Filing
Aug 26, 2024 1:28 PM

03:59 PM EDT, 08/26/2024 (MT Newswires) -- Felix The, Senior Vice President, Product and Technology, Grow, on August 23, 2024, sold 16,855 shares in Unity Software ( U ) for $300,525. Following the Form 4 filing with the SEC, The has control over a total of 459,951 shares of the company, with 459,951 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1810806/000181080624000206/xslF345X05/wk-form4_1724701999.xml

Price: 17.81, Change: -0.07, Percent Change: -0.39

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Anavex Life Sciences' Alzheimer's Drug Candidate Shows Continued Long-Term Benefit Versus Control Group
Anavex Life Sciences' Alzheimer's Drug Candidate Shows Continued Long-Term Benefit Versus Control Group
Oct 29, 2025
On Wednesday, Anavex Life Sciences Corp. ( AVXL ) announced new findings for blarcamesine, an oral small molecule for early Alzheimer's disease. AVXL stock is taking a breather. Get the market research here. New data demonstrate continued long-term benefit from oral blarcamesine compared to the decline observed in the Alzheimer's Disease Neuroimaging Initiative (ADNI) control group. Data Externally matched control...
Anavex Life Sciences' Alzheimer's Drug Candidate Shows Continued Long-Term Benefit Versus Control Group
Anavex Life Sciences' Alzheimer's Drug Candidate Shows Continued Long-Term Benefit Versus Control Group
Oct 29, 2025
On Wednesday, Anavex Life Sciences Corp. ( AVXL ) announced new findings for blarcamesine, an oral small molecule for early Alzheimer's disease. AVXL stock is taking a breather. Get the market research here. New data demonstrate continued long-term benefit from oral blarcamesine compared to the decline observed in the Alzheimer's Disease Neuroimaging Initiative (ADNI) control group. Data Externally matched control...
AutoCanada Names CFO Sam Cochrane Interim CEO as Paul Antony Steps Down from Executive Chair Role
AutoCanada Names CFO Sam Cochrane Interim CEO as Paul Antony Steps Down from Executive Chair Role
Oct 29, 2025
07:32 AM EDT, 10/29/2025 (MT Newswires) -- AutoCanada ( AOCIF ) , an automobile dealership group, overnight Tuesday said it appointed its chief financial officer, Sam Cochrane, as interim chief executive officer. A statement noted that, concurrently with Cochrane's appointment as interim CEO, Paul Antony is transitioning out of his role as AutoCanada's ( AOCIF ) executive chair and as...
IDEX Corp beats Q3 estimates on strong demand for health and science products
IDEX Corp beats Q3 estimates on strong demand for health and science products
Oct 29, 2025
Oct 29 (Reuters) - Industrial equipment maker IDEX Corp ( IEX ) on Wednesday posted a stronger-than-expected profit and revenue for the third quarter, helped by a protracted recovery in its health and science product lines. Sales in the health and science technology segment rose 22% from a year earlier, as customers continued to restock after working through the large...
Copyright 2023-2026 - www.financetom.com All Rights Reserved